Logo
Cedar Grove Capital Management
Search
Subscribe
Sign In
Home
Archive
Authors
Table of Contents
In the Press
Contact Us

HIMS: Andrew Dudum. The "Teflon Don" of Telehealth

Oct 17, 2025

•

30 min read

HIMS: Andrew Dudum. The "Teflon Don" of Telehealth

Why time might be ticking for HIMS to continue exploiting its GLP-1 loophole

Paul Cerro
Paul Cerro
HIMS: Another (Misleading) GLP-1 PR Claim

Jun 17, 2025

•

18 min read

HIMS: Another (Misleading) GLP-1 PR Claim

Why Andrew's recent Tweet is misleading and also, maybe self-incriminating?

Paul Cerro
Paul Cerro
A Bunch of Quick Position Updates

Jun 5, 2025

•

21 min read

A Bunch of Quick Position Updates

SHCO, LNSR, LQDA, CPRI, GENK, DKS, and HIMS

Paul Cerro
Paul Cerro
HIMS: Napoleon Begins His March Towards Russia?

Mar 3, 2025

•

4 min read

HIMS: Napoleon Begins His March Towards Russia?

Post-Q4 Earnings Commentary

Paul Cerro
Paul Cerro
Reiterating Short: HIMS CC Data Suggests Growth Massively 'Over-Indexing' Toward GLP-1s

Feb 18, 2025

•

29 min read

Reiterating Short: HIMS CC Data Suggests Growth Massively 'Over-Indexing' Toward GLP-1s

Previous estimates for GLP-1 contribution may have been seriously underestimated

Paul Cerro
Paul Cerro
🚩Alert on GEN Restaurant Group (GENK)

Feb 7, 2025

•

12 min read

🚩Alert on GEN Restaurant Group (GENK)

Why recent information has made us question the accuracy of unit history in filings

Paul Cerro
Paul Cerro
HIMS GLP-1 Shortage: The End is Nigh

Jan 27, 2025

•

24 min read

HIMS GLP-1 Shortage: The End is Nigh

An update on the semaglutide shortage + what happens after?

Paul Cerro
Paul Cerro
HIMS: "A Bridge Too Far"

Jan 12, 2025

•

17 min read

HIMS: "A Bridge Too Far"

Why we've decided to flip short on Hims and Hers Health (HIMS)

Paul Cerro
Paul Cerro
Performance Update: RCAT +53%; WW +84%

Aug 16, 2024

•

9 min read

Performance Update: RCAT +53%; WW +84%

Updated commentary on Red Cat and Weight Watchers post-earnings

Paul Cerro
Paul Cerro

Cedar Grove Capital Management

Multi-strategy equity research focused on L/S, M&A Arb, and other Special Situations.

© 2025 Cedar Grove Capital Management.

Privacy policy

Terms of use

Powered by beehiiv